AstraZeneca PLC Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 62.89 M | $4.90 B | -3.15% | 2.03% |
PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 41.98 M | $3.27 B | -1.45% | 1.35% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 37.25 M | $2.90 B | -8.19% | 1.20% |
CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 36.82 M | $2.87 B | 0.32% | 1.19% |
FMR LLC | 11/13/2024 | 23.12 M | $1.80 B | 1.13% | 0.75% |
FRANKLIN RESOURCES INC | 11/27/2024 | 19.12 M | $1.49 B | 8.65% | 0.62% |
SANDERS CAPITAL, LLC | 11/13/2024 | 14.97 M | $1.17 B | 0.20% | 0.48% |
JENNISON ASSOCIATES LLC | 11/08/2024 | 14.96 M | $1.17 B | -12.10% | 0.48% |
MORGAN STANLEY | 11/14/2024 | 12.82 M | $999.19 M | 3.42% | 0.41% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 12.05 M | $938.53 M | -3.60% | 0.39% |
FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 10.48 M | $816.51 M | 5.26% | 0.34% |
CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 9.09 M | $708.23 M | -1.33% | 0.29% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 8.30 M | $647.02 M | -47.64% | 0.27% |
CAPITAL WORLD INVESTORS | 11/13/2024 | 6.25 M | $487.25 M | 0.04% | 0.20% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.15 M | $479.21 M | 100.00% | 0.20% |
GQG PARTNERS LLC | 11/13/2024 | 5.48 M | $426.57 M | 82.53% | 0.18% |
JPMORGAN CHASE & CO | 11/08/2024 | 5.32 M | $414.69 M | 24.52% | 0.17% |
NEUBERGER BERMAN GROUP LLC | 11/14/2024 | 5.23 M | $407.70 M | -3.21% | 0.17% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 5.04 M | $392.78 M | -5.02% | 0.16% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 4.69 M | $365.03 M | 5.43% | 0.15% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 4.29 M | $333.99 M | -12.18% | 0.14% |
WCM INVESTMENT MANAGEMENT, LLC | 11/04/2024 | 3.94 M | $305.70 M | -1.20% | 0.13% |
CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 3.58 M | $279.17 M | 5.27% | 0.12% |
ENVESTNET ASSET MANAGEMENT INC | 11/07/2024 | 3.52 M | $274.07 M | 2.92% | 0.11% |
FAYEZ SAROFIM & CO | 11/14/2024 | 3.44 M | $268.32 M | 6.32% | 0.11% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 3.38 M | $263.24 M | -8.36% | 0.11% |
MANNING & NAPIER ADVISORS LLC | 10/17/2024 | 3.18 M | $247.85 M | 31.64% | 0.10% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 3.07 M | $238.40 M | 109.57% | 0.10% |
INVESCO LTD. | 11/12/2024 | 2.94 M | $228.83 M | -8.71% | 0.09% |
SWEDBANK AB | 10/11/2024 | 2.71 M | $210.81 M | 1.31% | 0.09% |
SOROS FUND MANAGEMENT LLC | 11/14/2024 | 2.65 M | $206.68 M | 8.21% | 0.09% |
ROYAL BANK OF CANADA | 11/14/2024 | 2.49 M | $194.09 M | 2.12% | 0.08% |
RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 2.43 M | $189.26 M | -5.72% | 0.08% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 2.26 M | $175.73 M | 35.47% | 0.07% |
EPOCH INVESTMENT PARTNERS, INC. | 11/13/2024 | 1.96 M | $152.86 M | -14.29% | 0.06% |
NATIXIS ADVISORS, L.P. | 11/06/2024 | 1.96 M | $152.77 M | 6.35% | 0.06% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 1.88 M | $146.34 M | -1.14% | 0.06% |
STATE STREET CORP | 11/14/2024 | 1.82 M | $141.61 M | -21.98% | 0.06% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.78 M | $139.01 M | 0.50% | 0.06% |
UBS GROUP AG | 11/14/2024 | 1.75 M | $136.52 M | -4.37% | 0.06% |
SATURNA CAPITAL CORP | 11/05/2024 | 1.67 M | $130.49 M | 0.16% | 0.05% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.67 M | $130.08 M | 5.40% | 0.05% |
D. E. SHAW & CO., INC. | 11/14/2024 | 1.59 M | $123.99 M | 4,671.98% | 0.05% |
CRAWFORD INVESTMENT COUNSEL INC | 11/14/2024 | 1.54 M | $119.67 M | -0.64% | 0.05% |
ABRDN PLC | 10/25/2024 | 1.36 M | $106.14 M | -9.57% | 0.04% |
STIFEL FINANCIAL CORP | 11/14/2024 | 1.35 M | $105.09 M | 6.60% | 0.04% |
AGF MANAGEMENT LTD | 11/12/2024 | 1.34 M | $104.41 M | 2.80% | 0.04% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 1.33 M | $102.91 M | -11.99% | 0.04% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.29 M | $100.84 M | -41.60% | 0.04% |
LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 1.16 M | $90.44 M | -39.56% | 0.04% |
AstraZeneca PLCinstitutional Ownership - FAQ's
During the previous two years, 1608 institutional investors and hedge funds held shares of AstraZeneca PLC. The most heavily invested institutionals were:
PRICE T ROWE ASSOCIATES INC /MD/: 62.89 M
PRIMECAP MANAGEMENT CO/CA/: 41.98 M
WELLINGTON MANAGEMENT GROUP LLP: 37.25 M
Capital International Investors: 36.82 M
FMR LLC: 23.12 M
FRANKLIN RESOURCES INC: 19.12 M
15.54% of AstraZeneca PLC stock is owned by institutional investors.
Institutional investors have bought a total of 533.74 M shares in the last 24 months. This purchase volume represents approximately $34.89 B in transactions.